XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash $ 27,328,628 $ 455,366
Accounts receivable, net of allowances of $98,257 and $100,189 2,463,082 2,217,533
Royalty receivable 49,344 49,344
Inventory, net of allowance for obsolescence of $277,764 and $276,603 1,178,894 1,148,253
Prepaid and other assets 520,060 611,817
Total current assets 31,540,008 4,482,313
Long-term assets    
Property, plant and equipment, net of accumulated depreciation of $142,179 and $124,691 1,665,492 678,589
Right of use assets - operating leases 437,081 467,653
Intangible assets, net of accumulated amortization of $900,211 and $827,108 3,774,563 3,097,666
Investment in equity securities 1,600,865 1,100,000
Total long-term assets 7,478,001 5,343,908
Total assets 39,018,009 9,826,221
Current liabilities    
Accounts payable 280,321 271,251
Accounts payable - related parties 86,592 223,589
Accrued royalties and expenses 431,537 502,191
Accrued bonus and commissions 2,207,170 2,417,277
Operating lease liability - current 126,933 125,587
Total current liabilities 3,132,553 3,539,895
Long-term liabilities    
Operating lease liability - long term 323,528 355,797
Other long-term liabilities 90,293 90,293
Total long-term liabilities 413,821 446,090
Total liabilities 3,546,374 3,985,985
Shareholders' equity    
Common Stock: $0.001 par value, 20,000,000 shares authorized; 7,617,122 issued and outstanding as of March 31, 2021 and 6,297,008 issued and outstanding as of December 31, 2020 7,617 6,297
Additional paid-in capital 44,190,031 13,176,576
Accumulated deficit (8,213,986) (7,032,242)
Total Sanara MedTech shareholders' equity 35,983,662 6,150,631
Equity attributable to noncontrolling interest (512,027) (310,395)
Total shareholders' equity 35,471,635 5,840,236
Total liabilities and shareholders' equity $ 39,018,009 $ 9,826,221